We intend to focus on the medical technology sector. Our management team and board (collectively referred to as the “team”) possess a synergistic combination of executive, strategic, operational, financial and transactional experience in this sector, and have demonstrated a strong track record of identifying and creating significant stockholder value at leading medical technology companies. 

(Note: Priveterra Acquisition Corp. priced its upsized IPO on Feb. 8, 2021, of 24 million units, up from 20 million, at $10 each to raise $240 million.)